481 results on '"Nout, Remi"'
Search Results
2. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
3. Assessment of integrated electromagnetic tracking for dwell position monitoring in a clinical HDR brachytherapy setting for prostate cancer
4. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
5. Time-action and patient experience analyses of locally advanced cervical cancer brachytherapy
6. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
7. HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial
8. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
9. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
10. Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE
11. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
12. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer
13. ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer
14. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
15. Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
16. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
17. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer
18. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
19. GEC-ESTRO (ACROP)–ABS–CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina
20. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
21. Automated causal inference in application to randomized controlled clinical trials
22. Postgraduate education in radiation oncology during the COVID-19 pandemic – What did we learn?
23. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study
24. Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
25. Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
26. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer
27. Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile
28. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
29. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
30. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
31. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
32. Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors
33. Uterine serous carcinoma
34. Drug repurposing as a potential source of innovative therapies in cervical cancer
35. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
36. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
37. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
38. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study
39. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
40. Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer
41. Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective
42. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
43. RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
44. Multibody dynamic modeling of the behavior of flexible instruments used in cervical cancer brachytherapy.
45. Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer
46. Late, Persistent, Substantial, Treatment-Related Symptoms After Radiation Therapy (LAPERS): A New Method for Longitudinal Analysis of Late Morbidity—Applied in the EMBRACE Study
47. Reporting of Late Morbidity After Radiation Therapy in Large Prospective Studies: A Descriptive Review of the Current Status
48. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
49. Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer: Evolution of Practice From EMBRACE-I to II
50. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.